CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||
(In thousands) | ||||
(Unaudited) | ||||
|
First Three Quarters of | |||
|
2014 |
|
2013 | |
|
|
|
| |
Cash flow from operating activities: |
|
|
| |
Net Income |
$ 158,027 |
|
$ 158,505 | |
|
|
|
| |
Adjustments to reconcile net income to net cash provided by |
|
|
| |
operating activities: |
|
|
| |
Depreciation expense |
24,068 |
|
19,630 | |
Amortization expense |
117,769 |
|
120,713 | |
Provision for doubtful accounts |
2,887 |
|
1,204 | |
Deferred income taxes |
(1,193) |
|
(13,520) | |
Stock-based compensation |
32,125 |
|
26,158 | |
Income from equity method investments |
(11,528) |
|
(15,908) | |
Gain on an equity sale |
(15,091) |
|
- | |
Excess tax benefit for stock-based compensation |
(14,094) |
|
(8,803) | |
Provision for excess and obsolete inventories |
3,553 |
|
1,551 | |
Other non-cash items |
5,422 |
|
738 | |
|
|
|
| |
Add decrease (increase) in assets: |
|
|
| |
Accounts receivables |
(12,742) |
|
(28,466) | |
Other receivables |
(4,709) |
|
4,047 | |
Inventories |
(27,234) |
|
2,645 | |
Other current and non-current assets |
(12,929) |
|
(22,765) | |
|
|
|
| |
Add increase (decrease) in liabilities: |
|
|
| |
Accounts payable |
(6,745) |
|
(22,467) | |
Accrued compensation and benefits |
(9,321) |
|
(2,738) | |
Deferred revenue |
41,861 |
|
46,891 | |
Accrued warranty expense |
2,735 |
|
347 | |
Other liabilities |
37,603 |
|
10,646 | |
Net cash provided by operating activities |
310,464 |
|
278,408 | |
|
|
|
| |
Cash flow from investing activities: |
|
|
| |
Acquisitions of businesses, net of cash acquired |
(170,863) |
|
(200,401) | |
Acquisitions of property and equipment |
(34,952) |
|
(57,646) | |
Acquisitions of intangible assets |
(7,007) |
|
(105) | |
(Purchases) sales of equity method investments |
(10,939) |
|
2,429 | |
Dividends received from equity method investments |
25,850 |
|
7,672 | |
Increase in restricted cash |
- |
|
(6,696) | |
Other |
(4,532) |
|
(1,661) | |
Net cash used in investing activities |
(202,443) |
|
(256,408) | |
|
|
|
| |
Cash flow from financing activities: |
|
|
| |
Issuance of common stock, net of tax withholdings |
53,601 |
|
37,667 | |
Repurchase and retirement of common stock |
(64,978) |
|
- | |
Excess tax benefit for stock-based compensation |
14,094 |
|
8,803 | |
Proceeds from debt and revolving credit lines |
32,027 |
|
332,021 | |
Payments on debt and revolving credit lines |
(143,274) |
|
(440,886) | |
Net cash used in financing activities |
(108,530) |
|
(62,395) | |
|
|
|
| |
Effect of exchange rate changes on cash and cash equivalents |
(7,241) |
|
(2,119) | |
|
|
|
| |
Net decrease in cash and cash equivalents |
(7,750) |
|
(42,514) | |
Cash and cash equivalents - beginning of period |
147,227 |
|
157,771 | |
|
|
|
| |
Cash and cash equivalents - end of period |
$ 139,477 |
|
$ 115,257 |